Phase 3 Trial of mRNA-1273 during the Delta-Variant Surge

N Engl J Med. 2021 Dec 23;385(26):2485-2487. doi: 10.1056/NEJMc2115597. Epub 2021 Nov 3.

Authors

Lindsey R Baden¹, Hana M El Sahly², Brandon Essink³, Dean Follmann⁴, Kathleen M Neuzil⁵, Allison August⁶, Heather Clouting⁶, Gabrielle Fortier⁶, Weiping Deng⁶, Shu Han⁶, Xiaoping Zhao⁶, Brett Leav⁶, Carla Talarico⁶, Bethany Girard⁶, Yamuna D Paila⁶, Joanne E Tomassini⁶, Florian Schödel⁶, Rolando Pajon⁶, Honghong Zhou⁶, Rituparna Das⁶, Jacqueline Miller⁶

Affiliations

¹ Brigham and Women's Hospital, Boston, MA [email protected].
² Baylor College of Medicine, Houston, TX [email protected].
³ Meridian Clinical Research, Omaha, NE.
⁴ National Institute of Allergy and Infectious Diseases, Bethesda, MD.
⁵ University of Maryland, Baltimore, MD.
⁶ Moderna, Cambridge, MA.

No abstract available

Publication types

Letter

Grants and funding